modelos in vitro 2.docx

Embed Size (px)

Citation preview

  • 8/11/2019 modelos in vitro 2.docx

    1/2

    PAMPAFrom Wikipedia, the free encyclopedia

    PAMPA(parallel artificial membrane permeability assay) is a method which determines thepermeability of substances from a donor compartment, through alipid-infused artificial

    membrane into an acceptor compartment. A multi-well microtitre plate is used for the donorand a membrane/acceptor compartment is placed on top; the whole assembly is commonlyreferred to as a sandwich. At the beginning of the test, the drug is added to the donorcompartment, and the acceptor compartment is drug-free. After an incubation period whichmay include stirring, the sandwich is separated and the amount of drug is measured ineach compartment. Mass balance allows calculation of drug that remains in the membrane.To date, PAMPA models have been developed that exhibit a high degree of correlation withpermeation across a variety of barriers, includingCaco-2cultures,[1][2]thegastrointestinaltract,[3]bloodbrain barrier[4]and skin.

    The donor and/or acceptor compartments may contain solubilizing agents, or additives thatbind the drugs as they permeate. To improve thein vitro-in vivocorrelation andperformance of the PAMPA method, the lipid, pH and chemical composition of the system

    is often designed with biomimetic considerations in mind.

    The popularity of PAMPA inADMEscreening attests to its utility as an early stage, low-costalternative to cellular models for research compounds. Althoughactive transportis notmodeled by the artificial PAMPA membrane, up to 95% of known drugs are absorbedbypassive transport.[5]Some experts support a lower figure, so the amount is open to someinterpretation. Microtiter plates with 96 wells can be used for the assay which increases thespeed and lowers the per sample cost.

    Since the first publication by Kansy and coworkers,[6]several companies developed theirown versions of the assay. Early models incorporated iso-pH conditions in thecompartments separated by a simple lipid membrane; subsequently, commercial productswere introduced which incorporated more sophisticated lipid membranes.[7]The commercial

    products helped ensure that medicinal chemists across different corporate labs within aworldwide organization used the same standardized methodology, reagents and obtainedequivalent system performance as demonstrated with a set of test compounds. This hasproved very useful as various operational activities have been outsourced to othercountries.

    As financial and other factors in pharmaceutical development continue to strain timelinesand resources, PAMPA will most likely continue to play an ever-increasing role inlaboratories wishing to increase their operating efficiencies and success rate.

    Caco-2From Wikipedia, the free encyclopedia

    The Caco-2cell line is a continuous cellofheterogeneoushumanepithelialcolorectaladenocarcinomacells, developed bytheSloan-Kettering Institute for Cancer Researchthrough research conducted by Dr.Jorgen Fogh.[1]

    Although derived from a colon (large intestine)carcinoma,when cultured under specificconditions the cells become differentiated and polarized such that theirphenotype,morphologically and functionally, resembles theenterocyteslining thesmallintestine.[2][3]Caco-2 cells express tight junctions,microvilli,and a number ofenzymesandtransporters that are characteristic of such enterocytes:peptidases,esterases,P-glycoprotein,uptake transporters foramino acids,bile acidscarboxylic acids,etc. They arecommercially available through theAmerican Type Culture Collection(ATCC; Manassas,VA, USA).

    http://en.wikipedia.org/wiki/Lipidhttp://en.wikipedia.org/wiki/Lipidhttp://en.wikipedia.org/wiki/Lipidhttp://en.wikipedia.org/wiki/Caco-2http://en.wikipedia.org/wiki/Caco-2http://en.wikipedia.org/wiki/Caco-2http://en.wikipedia.org/wiki/PAMPA#cite_note-1http://en.wikipedia.org/wiki/PAMPA#cite_note-1http://en.wikipedia.org/wiki/PAMPA#cite_note-1http://en.wikipedia.org/wiki/Gastrointestinal_tracthttp://en.wikipedia.org/wiki/Gastrointestinal_tracthttp://en.wikipedia.org/wiki/Gastrointestinal_tracthttp://en.wikipedia.org/wiki/PAMPA#cite_note-3http://en.wikipedia.org/wiki/PAMPA#cite_note-3http://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/In_vitrohttp://en.wikipedia.org/wiki/In_vitrohttp://en.wikipedia.org/wiki/In_vitrohttp://en.wikipedia.org/wiki/In_vivohttp://en.wikipedia.org/wiki/In_vivohttp://en.wikipedia.org/wiki/In_vivohttp://en.wikipedia.org/wiki/ADMEhttp://en.wikipedia.org/wiki/ADMEhttp://en.wikipedia.org/wiki/ADMEhttp://en.wikipedia.org/wiki/Active_transporthttp://en.wikipedia.org/wiki/Active_transporthttp://en.wikipedia.org/wiki/Active_transporthttp://en.wikipedia.org/wiki/Passive_transporthttp://en.wikipedia.org/wiki/Passive_transporthttp://en.wikipedia.org/wiki/PAMPA#cite_note-5http://en.wikipedia.org/wiki/PAMPA#cite_note-5http://en.wikipedia.org/wiki/PAMPA#cite_note-5http://en.wikipedia.org/wiki/PAMPA#cite_note-6http://en.wikipedia.org/wiki/PAMPA#cite_note-6http://en.wikipedia.org/wiki/PAMPA#cite_note-6http://en.wikipedia.org/wiki/PAMPA#cite_note-7http://en.wikipedia.org/wiki/PAMPA#cite_note-7http://en.wikipedia.org/wiki/Heterogeneoushttp://en.wikipedia.org/wiki/Heterogeneoushttp://en.wikipedia.org/wiki/Humanhttp://en.wikipedia.org/wiki/Humanhttp://en.wikipedia.org/wiki/Epitheliumhttp://en.wikipedia.org/wiki/Epitheliumhttp://en.wikipedia.org/wiki/Colon_(anatomy)http://en.wikipedia.org/wiki/Colon_(anatomy)http://en.wikipedia.org/wiki/Adenocarcinomahttp://en.wikipedia.org/wiki/Adenocarcinomahttp://en.wikipedia.org/wiki/Adenocarcinomahttp://en.wikipedia.org/wiki/Memorial_Sloan-Kettering_Cancer_Centerhttp://en.wikipedia.org/wiki/Memorial_Sloan-Kettering_Cancer_Centerhttp://en.wikipedia.org/wiki/Memorial_Sloan-Kettering_Cancer_Centerhttp://en.wikipedia.org/wiki/Caco-2#cite_note-1http://en.wikipedia.org/wiki/Caco-2#cite_note-1http://en.wikipedia.org/wiki/Caco-2#cite_note-1http://en.wikipedia.org/wiki/Large_intestinehttp://en.wikipedia.org/wiki/Large_intestinehttp://en.wikipedia.org/wiki/Large_intestinehttp://en.wikipedia.org/wiki/Carcinomahttp://en.wikipedia.org/wiki/Carcinomahttp://en.wikipedia.org/wiki/Carcinomahttp://en.wikipedia.org/wiki/Phenotypehttp://en.wikipedia.org/wiki/Phenotypehttp://en.wikipedia.org/wiki/Phenotypehttp://en.wikipedia.org/wiki/Enterocyteshttp://en.wikipedia.org/wiki/Enterocyteshttp://en.wikipedia.org/wiki/Enterocyteshttp://en.wikipedia.org/wiki/Small_intestinehttp://en.wikipedia.org/wiki/Small_intestinehttp://en.wikipedia.org/wiki/Small_intestinehttp://en.wikipedia.org/wiki/Caco-2#cite_note-2http://en.wikipedia.org/wiki/Caco-2#cite_note-2http://en.wikipedia.org/wiki/Caco-2#cite_note-2http://en.wikipedia.org/wiki/Microvillihttp://en.wikipedia.org/wiki/Microvillihttp://en.wikipedia.org/wiki/Microvillihttp://en.wikipedia.org/wiki/Enzymeshttp://en.wikipedia.org/wiki/Enzymeshttp://en.wikipedia.org/wiki/Enzymeshttp://en.wikipedia.org/wiki/Peptidasehttp://en.wikipedia.org/wiki/Peptidasehttp://en.wikipedia.org/wiki/Peptidasehttp://en.wikipedia.org/wiki/Esteraseshttp://en.wikipedia.org/wiki/Esteraseshttp://en.wikipedia.org/wiki/Esteraseshttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/Amino_acidshttp://en.wikipedia.org/wiki/Amino_acidshttp://en.wikipedia.org/wiki/Amino_acidshttp://en.wikipedia.org/wiki/Carboxylic_acidshttp://en.wikipedia.org/wiki/Carboxylic_acidshttp://en.wikipedia.org/wiki/Carboxylic_acidshttp://en.wikipedia.org/wiki/American_Type_Culture_Collectionhttp://en.wikipedia.org/wiki/American_Type_Culture_Collectionhttp://en.wikipedia.org/wiki/American_Type_Culture_Collectionhttp://en.wikipedia.org/wiki/American_Type_Culture_Collectionhttp://en.wikipedia.org/wiki/Carboxylic_acidshttp://en.wikipedia.org/wiki/Amino_acidshttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/P-glycoproteinhttp://en.wikipedia.org/wiki/Esteraseshttp://en.wikipedia.org/wiki/Peptidasehttp://en.wikipedia.org/wiki/Enzymeshttp://en.wikipedia.org/wiki/Microvillihttp://en.wikipedia.org/wiki/Caco-2#cite_note-2http://en.wikipedia.org/wiki/Caco-2#cite_note-2http://en.wikipedia.org/wiki/Small_intestinehttp://en.wikipedia.org/wiki/Small_intestinehttp://en.wikipedia.org/wiki/Enterocyteshttp://en.wikipedia.org/wiki/Phenotypehttp://en.wikipedia.org/wiki/Carcinomahttp://en.wikipedia.org/wiki/Large_intestinehttp://en.wikipedia.org/wiki/Caco-2#cite_note-1http://en.wikipedia.org/wiki/Memorial_Sloan-Kettering_Cancer_Centerhttp://en.wikipedia.org/wiki/Adenocarcinomahttp://en.wikipedia.org/wiki/Colon_(anatomy)http://en.wikipedia.org/wiki/Epitheliumhttp://en.wikipedia.org/wiki/Humanhttp://en.wikipedia.org/wiki/Heterogeneoushttp://en.wikipedia.org/wiki/PAMPA#cite_note-7http://en.wikipedia.org/wiki/PAMPA#cite_note-6http://en.wikipedia.org/wiki/PAMPA#cite_note-5http://en.wikipedia.org/wiki/Passive_transporthttp://en.wikipedia.org/wiki/Active_transporthttp://en.wikipedia.org/wiki/ADMEhttp://en.wikipedia.org/wiki/In_vivohttp://en.wikipedia.org/wiki/In_vitrohttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/Blood%E2%80%93brain_barrierhttp://en.wikipedia.org/wiki/PAMPA#cite_note-3http://en.wikipedia.org/wiki/Gastrointestinal_tracthttp://en.wikipedia.org/wiki/Gastrointestinal_tracthttp://en.wikipedia.org/wiki/PAMPA#cite_note-1http://en.wikipedia.org/wiki/PAMPA#cite_note-1http://en.wikipedia.org/wiki/Caco-2http://en.wikipedia.org/wiki/Lipid
  • 8/11/2019 modelos in vitro 2.docx

    2/2

    When looking at Caco-2 cell cultures microscopically, it is evident even by visual inspectionthat the cells are heterogeneous. As a result, over the years the characteristics of the cellsused in different laboratories around the world have diverged significantly, which makes itdifficult to compare results across labs.[4]

    Caco-2 cells are most commonly used not as individual cells, but as a

    confluentmonolayeron a cell culture insert filter (e.g., Transwell). When cultured in thisformat, the cells differentiate to form a polarized epithelial cell monolayer that provides aphysical and biochemical barrier to the passage of ions and small molecules.[3][5]The Caco-2 monolayer is widely used across the pharmaceutical industry as an in vitro model of thehuman small intestinal mucosa to predict the absorption of orally administered drugs. Thecorrelation between the in vitro apparent permeability (Papp) across Caco-2 monolayersand the in vivo fraction absorbed (fa) is well established.[6]Transwell diagram

    This application of Caco-2 cells was pioneered in the late 1980s by Ismael Hidalgo, workingin the laboratory of Ron Borchardt at the University of Kansas, and Tom Raub, who was attheUpjohn Companyat the time. Following stints atSmithKline BeechamandRhone-Poulenc Rorer,Hidalgo went on to co-found a company,Absorption Systems,in 1996,where he remains as Chief Scientist.

    The considerable impact of the Caco-2 cell monolayer model can be measured in at leasttwo ways. First, considering that poorpharmacokineticproperties accounted for ~40% ofdrug failures in development in the early 1990s and only ~10% by 2009, an interval inwhich Caco-2 monolayers were widely used throughout thepharmaceutical industrytopredict absorption, it is not unreasonable to attribute some of that shift to this simple yetpowerful model. Second, the 1989 Gastroenterology paper that demonstrated the utility ofthe model for this application has been cited more than 1000 times since its publication.

    The versatility of Caco-2 cells is demonstrated by the fact that, even to this day, they areserving as the basis for the creation of innovative new models that are contributing to ourunderstanding of drug efflux transporters such as P-glycoprotein (ABCB1) and BCRP(ABCG2). RNA interference has been used to silence the expression of individual effluxtransporters, either transiently[7]or long-term.[8][9]

    http://en.wikipedia.org/wiki/Caco-2#cite_note-4http://en.wikipedia.org/wiki/Caco-2#cite_note-4http://en.wikipedia.org/wiki/Caco-2#cite_note-4http://en.wikipedia.org/wiki/Monolayerhttp://en.wikipedia.org/wiki/Monolayerhttp://en.wikipedia.org/wiki/Monolayerhttp://en.wikipedia.org/wiki/Caco-2#cite_note-pmid2914637-3http://en.wikipedia.org/wiki/Caco-2#cite_note-pmid2914637-3http://en.wikipedia.org/wiki/Caco-2#cite_note-pmid2914637-3http://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Upjohn_Companyhttp://en.wikipedia.org/wiki/Upjohn_Companyhttp://en.wikipedia.org/wiki/Upjohn_Companyhttp://en.wikipedia.org/wiki/SmithKline_Beechamhttp://en.wikipedia.org/wiki/SmithKline_Beechamhttp://en.wikipedia.org/wiki/SmithKline_Beechamhttp://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://www.absorption.com/Site/http://www.absorption.com/Site/http://www.absorption.com/Site/http://en.wikipedia.org/wiki/Pharmacokinetichttp://en.wikipedia.org/wiki/Pharmacokinetichttp://en.wikipedia.org/wiki/Pharmacokinetichttp://en.wikipedia.org/wiki/Pharmaceutical_industryhttp://en.wikipedia.org/wiki/Pharmaceutical_industryhttp://en.wikipedia.org/wiki/Pharmaceutical_industryhttp://en.wikipedia.org/wiki/Caco-2#cite_note-7http://en.wikipedia.org/wiki/Caco-2#cite_note-7http://en.wikipedia.org/wiki/Caco-2#cite_note-7http://en.wikipedia.org/wiki/Caco-2#cite_note-8http://en.wikipedia.org/wiki/Caco-2#cite_note-8http://en.wikipedia.org/wiki/Caco-2#cite_note-8http://en.wikipedia.org/wiki/Caco-2#cite_note-8http://en.wikipedia.org/wiki/Caco-2#cite_note-8http://en.wikipedia.org/wiki/Caco-2#cite_note-7http://en.wikipedia.org/wiki/Pharmaceutical_industryhttp://en.wikipedia.org/wiki/Pharmacokinetichttp://www.absorption.com/Site/http://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://en.wikipedia.org/wiki/Rhone-Poulenc_Rorerhttp://en.wikipedia.org/wiki/SmithKline_Beechamhttp://en.wikipedia.org/wiki/Upjohn_Companyhttp://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Caco-2#cite_note-6http://en.wikipedia.org/wiki/Caco-2#cite_note-pmid2914637-3http://en.wikipedia.org/wiki/Caco-2#cite_note-pmid2914637-3http://en.wikipedia.org/wiki/Monolayerhttp://en.wikipedia.org/wiki/Caco-2#cite_note-4